Gedeon Richter PLC
RGEDF
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.26T
Close$
Share Statistics
| Market cap | $2.26 Trillion |
|---|---|
| Enterprise Value | $2.02 Trillion |
| Dividend Yield | $2.15 (5.31%) |
| Earnings per Share | $1263.79 |
| Beta | 0.34 |
| Outstanding Shares | 183,075,000 |
Return
| Return on Equity | 15.74% |
|---|---|
| Return on Assets | 13.03% |
| Return on Invested Capital | 18.30% |
Valuation & Multiples
| P/E Ratio | 9.83 |
|---|---|
| PEG | -234.43 |
| Price to Sales | 0.01 |
| Price to Book Ratio | 0.0 |
| Enterprise Value to Revenue | 2.18 |
| Enterprise Value to EBIT | 6.98 |
| Enterprise Value to Net Income | 8 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 7, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$753.95 M
Average shareholder expectationNext Earnings Call
Expected Date
November 10, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Gedeon Richter PLC
11,955 employees
CEO: Gabor Orban Gedeon Richter Plc is a company focused on the development and manufacturing of pharmaceutical products. Its operations are organized into three primary divisions: Pharmaceuticals, Wholesale & Retail, and Other. The Pharmaceutical segmen...